ARIAD PHARMACEUTIC (NASDAQ:ARIA)
2.23
+0.01 (0.45%)
| ARIAD PHARMACEUTIC (NASDAQ:ARIA) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $3.48 | ||
| Open | $2.21 | 52 Week Low | $0.72 | ||
| Day High | $2.25 | P/E | N/A | ||
| Day Low | $2.18 | EPS | $-0.95 | ||
| Volume | 680,294 | ||||
| More ARIA Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| ANDS | 3 | ENOC | 3 |
| S | 3 | SYNA | 3 |
| GXDX | 3 | LVS | 3 |
| RPRX | 2 | FSLR | 2 |
| ODP | 2 | PBI | 2 |
| DT | 2 | PKI | 2 |
Entities who have mentioned ARIA
- Merriman Curhan Ford | View Related Stories »
- JPMorgan | View Related Stories »
- Jefferies & Co | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Citi | View Related Stories »
- Robert W Baird | View Related Stories »
- Lazard | View Related Stories »
- Daniel Loeb | View Related Stories »
- Third Point LLC | View Related Stories »
- After-Hours Movers | View Related Stories »
- ThinkEquity | View Related Stories »
- Wedbush Morgan | View Related Stories »
- UBS | View Related Stories »
- Trading Radar | View Related Stories »
- Deutsche Bank | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Credit Suisse | View Related Stories »
- FDIC | View Related Stories »
- Canaccord Adams | View Related Stories »
- William Blair | View Related Stories »
- Needham & Co | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Collins Stewart | View Related Stories »
View All Major News StreetInsider.com Major News for ARIA
- ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
- ARIAD Pharmaceuticals (ARIA) Drop in After Hours After Update on Business Outlook
- ARIAD Pharmaceuticals (ARIA) Reports Q2 Loss
View All ReportsStreetInsider.com Reports on ARIA
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
- JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight
- ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Ariad Pharma (ARIA) Announced Publication of AP24534 in Scientific Journal Cancer Cell as a Premier Pan BCR-ABL Inhibitor
View All Press ReleasesCompany Press Releases on ARIA
- ARIAD to Present Data on Pan-BCR-ABL Inhibitor AP24534 at 51st American Society of Hematology Meeting
- ARIAD to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
- ARIAD's AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor
- ARIAD to Present at the Oppenheimer 20th Annual Healthcare Conference
StreetInsider Reports on ARIA by Category
View All BlogsBlogs on ARIA
- Monday Options Recap
- Analyst upgrades, downgrades and initiations: ANF, AZN, BX, GPS, PH, RAIL, VRSN ...
- Readers Ask: Adventrix, Ariad Pharmaceuticals
- Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
- Closing Update: Stocks Manage Narrowly Higher Finish
View All FilingsSEC Filings on ARIA
- Form 10-Q ARIAD PHARMACEUTICALS For: Sep 30
- Form 8-K ARIAD PHARMACEUTICALS For: Nov 05
- Form 4 IULIUCCI JOHN D For: Oct 01
Comments on ARIA
No comments are currently available.
